project id: TCGA-HNSC; case submitter id: TCGA-CV-A45Y; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.94; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.43; rna integrity number: 7.6; age at index: 61; days to birth: -22442; days to death: 2703; ethnicity: hispanic or latino; gender: male; race: american indian or alaska native; vital status: Dead; year of birth: 1939; year of death: 2007; age at diagnosis: 22442; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage IVA; ajcc clinical t: T4a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T4a; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2000; alcohol history: Yes; cigarettes per day: 2.136986301369863; pack years smoked: 39.0; years smoked: 39.0; is ffpe: false; composition: Not Reported; days to collection: 4481; days to sample procurement: 0; initial weight: 30.0; portion submitter id: TCGA-CV-A45Y-01A-11; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 5.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 15.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0;